BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7808968)

  • 1. Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV.
    Nerlich AG; Stöss H; Lehmann H; Krieg T; Müller PK
    Pathol Res Pract; 1994 Aug; 190(7):697-706; discussion 706-7. PubMed ID: 7808968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
    Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K
    Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies.
    Clark JG; Kuhn C; Uitto J
    Am Rev Respir Dis; 1980 Dec; 122(6):971-8. PubMed ID: 7458068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
    Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
    Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical, morphological and stereological study of the dermis in three members of a large family with type IV Ehlers-Danlos syndrome.
    Vitellaro-Zuccarello L; Dyne K; Cetta G
    Connect Tissue Res; 1989; 23(1):1-17. PubMed ID: 2632142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
    Byers PH; Holbrook KA; Barsh GS; Smith LT; Bornstein P
    Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
    Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
    Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ehlers-Danlos syndrome type VIII: biochemical, stereological and immunocytochemical studies on dermis from a child with clinical signs of Ehlers-Danlos syndrome and a family history of premature loss of permanent teeth.
    Dyne KM; Vitellaro-Zuccarello L; Bacchella L; Lanzi G; Cetta G
    Br J Dermatol; 1993 Apr; 128(4):458-63. PubMed ID: 8494762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural characteristics of the skin in a form of the Ehlers-Danlos syndrome type IV. Storage in the rough endoplasmic reticulum.
    Holbrook KA; Byers PH
    Lab Invest; 1981 Apr; 44(4):342-50. PubMed ID: 7193778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural study of the dermis in a case of type IV Ehlers-Danlos syndrome.
    Vitellaro-Zuccarello L; Cheli F; Esposito R; Bairati A
    J Submicrosc Cytol; 1985 Oct; 17(4):695-701. PubMed ID: 4078953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electron microscopic and immunohistological studies of a case of Ehlers-Danlos syndrome type IV].
    Matsuta M; Akasaka T; Kon S; Suzuki Z
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):601-7. PubMed ID: 2585774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV.
    Nuytinck L; Narcisi P; Nicholls A; Renard JP; Pope FM; De Paepe A
    J Med Genet; 1992 Jun; 29(6):375-80. PubMed ID: 1619632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunological studies of fibroblasts derived from a patient with Ehlers-Danlos syndrome type IV. Demonstrate reduced type III collagen synthesis.
    Aumailley M; Krieg T; Dessau W; Müller PK; Timpl R; Bricaud H
    Arch Dermatol Res; 1980; 269(2):169-77. PubMed ID: 7458408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ehlers-Danlos syndrome. Description of 2 clinical cases].
    Ottolini A; Berardinelli A; Besana D; Cetta G; Dyne KM; Lanzi G
    Minerva Pediatr; 1992 May; 44(5):231-6. PubMed ID: 1620075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collagen type I, III, IV and V and fibronectin in skin biopsies of patients with Ehlers-Danlos syndrome and cutis laxa].
    Shekhonin BV; Semiachkina AN; Makkaev KhM; Domogatskiĭ SP; Idel'son GL
    Arkh Patol; 1988; 50(12):41-8. PubMed ID: 3074749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.
    Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G
    Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome.
    Vogel A; Holbrook KA; Steinmann B; Gitzelmann R; Byers PH
    Lab Invest; 1979 Feb; 40(2):201-6. PubMed ID: 431039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Connective tissue pathology in patients with aneurysms of the cerebral arteries (Ehlers-Danlos syndrome)].
    Shishkina LV; Lazarev VA; Meshcheriakova AV; Printseva OIu
    Arkh Patol; 1993; 55(4):16-20. PubMed ID: 8311702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abdominal emergencies in type IV ehlers-Danlos syndrome].
    Benchellal ZA; Huten N; Danquechin Dorval E; Podeur L; Rahili A; Lemeret S; De Muret A
    Gastroenterol Clin Biol; 1998 Mar; 22(3):343-5. PubMed ID: 9762220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.